Investor buys Kenvue for steady dividends amid Wall Street's tech market worries

Investor Alex Sirois prefers buying Kenvue shares, which own trusted consumer brands like Tylenol and Band-Aid, due to their consistent demand and strong dividends. Despite Wall Street's concern over market reliance on a few tech giants, Kenvue offers a 4.8% dividend yield and reasonable valuation around 16 times earnings. The company is set to be acquired by Kimberly-Clark in a $48.7 billion deal expected to close in Q4 2026, providing additional value to shareholders. Risks include regulatory delays and ongoing litigation, but steady sales growth and rising free cash flow support the investment thesis.

Kenvue shares trade at USD 17.53 with a dividend yield of 4.79% as of Oct 08, 2026 19:02 WIB on Pluang, reflecting steady investor interest despite a slight 0.34% dip in one day. The stock's market cap stands at $33.67 billion, highlighting its significant presence in the consumer staples sector. This trading context complements the article's focus on Kenvue's appeal amid concerns about market concentration on Wall Street.